|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $0 and $60,551 at June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid cost of revenue | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Assets of business held for sale | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Prepaid cost of revenue, net of current portion | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible notes payable | ||||||||||||||||||||
| Liabilities of business held for sale | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||||||
| Loans payable, net of current portion | ||||||||||||||||||||
| Convertible notes payable, related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible notes payable, related party | ||||||||||||||||||||
| Lease liabilities, net of current portion | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Temporary Equity: Series B Preferred Stock; 2,396 shares issued at June 30, 2026 and December 31, 2025, respectively; 1,778 and 2,081 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Stockholders’ Equity: | ||||||||||||||||||||
| Common Stock, $.00001 par value; 1,300,000,000 shares authorized; 46,027,792 and 45,173,774 shares issued at June 30, 2026 and December 31, 2025, respectively; 45,525,655 and 44,671,637 outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Series A Preferred Stock, $.00001 par value; 50,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost (502,137 shares) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
